Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
Clinical trial NCT05199337 · COMPLETED
Trial details
- NCT number
- NCT05199337
- Sponsor
- K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2024-02-14
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.